EGFR and non-small cell lung carcinoma: In contrast, miR-27a, miR-21 and miR-218 have been verified to be significantly overexpressed in the plasma of EGFR TKI-resistant NSCLC patients compared with sensitive patients (p = 0.009, 0.004 and 0.041, respectively) [100].